Apo-Sulfatrim

2 months or older:
4 mg/kg (based on the trimethoprim component) orally every 12 hours for 10 to 14 days

Use: For the treatment of acute otitis media in pediatric patients due to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae when in the judgment of the physician sulfamethoxazole and trimethoprim offers some advantage over the use of other antimicrobial agents; sulfamethoxazole and trimethoprim is not indicated for prophylactic or prolonged administration in otitis media

CrCl less than 15 mL/min: Contraindicated
CrCl 15 to 30 mL/min: Reduce dose by 50%.
CrCl greater than 30 mL/min: Use standard dosing.